Discover and Track Domain Ratings to see how your site ranks against others worldwide
VerifiedDR is an authority-growth platform that turns your website’s backlink profile into actionable steps to improve Domain Rating (DR) and TrueDR, while connecting you with verified partners.
VerifiedDR is a web-based tool that analyzes your website’s backlink profile and produces a TrueDR score—a trust- and traffic-adjusted version of Ahrefs’ Domain Rating. It also generates prioritized authority-growth actions, matches you with relevant verified websites for backlink partnerships, and tracks DR changes daily. The product is created by VerifiedDR and targets site owners who want measurable authority gains.
Add your domain to get a free TrueDR and authority-gap analysis in under a minute. Then use the dashboard to track DR/TrueDR across all your sites, view a live authority feed, and start partner matches. Pro users receive weekly Authority Actions that, if completed, unlock the +10 DR guarantee.
Freemium model — free tier includes DR and TrueDR tracking, leaderboards, and 2 partner requests per month. Pro plan costs $99/month (billed monthly; $79/month when paid annually) and adds unlimited partner requests, AI visibility, index audits, backlink recovery, keyword opportunities, Slack/Discord alerts, and the +10 DR guarantee.
Yes. You can track your DR and TrueDR, explore partner matches, and send 2 partner requests per month with no credit card. The free tier also includes the authority feed and leaderboards.
Pro subscribers who complete at least 8 Authority Actions per month, start with DR ≤ 50, and keep their subscription active for 120 days get a full refund if DR hasn't risen by 10 points. Baseline DR is recorded in the DR Growth tracker.
DR (Domain Rating) is Ahrefs’ measure of backlink profile strength on a 0–100 scale. TrueDR adjusts DR for trust, traffic, domain age, and spam signals, so it can be lower when links appear low-quality or unsupported by real visitors.
Share feedback and ask questions about this launch.
No comments yet. Start the conversation!